Alerts
Holiday Hours Information

In recognition of the Christmas and New Year’s holidays, some of The University of Kansas Cancer Center’s offices will have modified hours on Wednesday, December 25, and Wednesday, January 1.

Skip Navigation

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors DAWT and Relapsed Favorable Histology Wilms Tumors FHWT

Brief Summary

Type:
Kidney

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04322318

Study #:
CMH - AREN1921

Start Date:
Nov 25, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04322318

View Complete Trial Details & Eligibility at ClinicalTrials.gov